Results 1 to 10 of about 11,782,455 (235)
Can Pharmacologic Therapy Induce Histologic Improvement in Non-alcoholic Steatohepatitis?
Articles: Farnesoid X Nuclear Receptor Ligand Obeticholic Acid for Non-cirrhotic, Non-alcoholic Steatohepatitis (FLINT): a Multicentre, Randomised, Placebo-controlled Trial (Lancet 2015;385:956-965) Liraglutide Safety and Efficacy in Patients with Non ...
Nae-Yun Heo
doaj +2 more sources
Сomparative Study of Progepar Efficacy in Patients with Non-Alcoholic Steatohepatitis
Non-alcoholic fatty liver disease is one of the most common pathologies of the liver in developed countries. On the average, its prevalence reaches 20 %.
V.G. Perederii, G.K. Syzenko
doaj +2 more sources
Background. The urgency of the problem of comorbidity of alcoholic steatohepatitis (ASH) and non-alcoholic steatohepatitis (NASH) with anaemic conditions and the need for their differentiated correction is determined by the significant frequency of these
T. Antofiichuk +3 more
doaj +1 more source
In case of non-alcoholic fatty liver disease, the ratio of serum aspartate aminotransferase (AST) level to platelet count index has been proposed as a non-invasive and readily available tool for the assessment of non-alcoholic steatohepatitis. The study
Dulal Chandra Das +5 more
doaj +1 more source
IMAGING DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS [PDF]
Non-alcoholic fatty liver comprises several clinical entities, starting from hepatic steatosis and reaching steatohepatitis, fibrosis and liver cirrhosis; it is currently considered a major public health issue.
Anca Smaranda Farmazon +6 more
doaj +1 more source
Non-alcoholic fatty liver disease (NAFLD) is categorised into simple steatosis, termed nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH).
Katarzyna Juszczyńska
doaj +1 more source
Diagnosis of Non-alcoholic fatty liver disease
Non Alcoholic Fatty Liver Disease is the deposition of fat in liver in absence of excessive of alcohol consumption. Non Alcoholic Fatty Liver Disease ranges from simple steatosis to Nonalcoholic steatohepatitis and cirrhosis.
Geetika K.C.
doaj +1 more source
Structure of anaemic conditions comorbid to alcoholic and non-alcoholic steatohepatitis
The retrospective analysis of 378 medical records of inpatients with steatohepatitis (SH) depending on its etiology was performed to identify and study the type of anaemic conditions (AC).
Oksana Khukhlina +2 more
doaj +1 more source
Non-alcoholic steatohepatitis (NASH) is an underdiagnosed liver disease characterized by steatosis, necroinflammation and fibrosis. This disease may eventually develop into cirrhosis and hepatocellular carcinoma. NASH is highly prevalent among obese individuals and among patients with diabetes mellitus type 2.
R, Vecchione +3 more
openaire +5 more sources
Introduction: Fatty liver disease (FLD) alcoholic and non-alcoholic are prevalent conditions. The damage is determined by steatosis and steatohepatitis with or without fibrosis.
Ana Jiménez +10 more
doaj +1 more source

